Riluzole 50 MG

DRUG2 trials

Sponsors

Cytokinetics, University of Utah

Conditions

Amyotrophic Lateral SclerosisAtrial Fibrillation Paroxysmal

Phase 2

Dose Titration Study to Test Safety and Effects of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)

CompletedNCT01486849

CytokineticsAmyotrophic Lateral Sclerosis

Start: 2011-11-30End: 2012-03-31Updated: 2019-05-03

RiLuzole to Reduce Atrial FIb Study Using Holter Monitoring

RecruitingNCT05292209

University of UtahAtrial Fibrillation Paroxysmal

Start: 2022-06-15End: 2024-10-30Target: 78Updated: 2023-11-24